| Gregory Graustein, LCDP | |
|
198 Central St # 200, Central Falls, RI 02863-2847 | |
| (401) 365-6811 | |
| (401) 365-6813 |
| Full Name | Gregory Graustein |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 198 Central St # 200, Central Falls, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518181114 | NPI | - | NPPES |
| GH57134 | Other | RI | GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | LCDP00004 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Graustein, LCDP 198 Central St # 200, Central Falls, RI 02863-2847 Ph: (401) 365-6811 | Gregory Graustein, LCDP 198 Central St # 200, Central Falls, RI 02863-2847 Ph: (401) 365-6811 |
News Archive
Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.
Approximately 10 percent of Medicare spending is for cancer care, and Medicare spending is nearly four times higher for beneficiaries with cancer than in those without the disease. Little is known about how to curb spending growth while maintaining or improving quality of care for these high-risk, high-cost patients.
About half of all girls at UK secondary schools might be avoiding sport because of embarrassment or pain caused by their breasts, according to new research.
Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced positive results from a skin moisturization study that compared the Company's recently launched BenzEFoam™ (benzoyl peroxide 5.3%) Emollient Foam to a market leading combination gel containing clindamycin 1% - benzoyl peroxide 5%. BenzEFoam™ Emollient Foam is indicated for the topical treatment of mild to moderate acne vulgaris and is the first prescription foam formulation containing benzoyl peroxide as the active ingredient.
› Verified 8 days ago
Ann Gardner, LMHC Counselor Medicare: Medicare Enrolled Practice Location: 621 Dexter St, Central Falls, RI 02863 Phone: 401-721-9200 Fax: 401-729-0010 | |
Angel Barraza, LCDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 51 Clay St, Central Falls, RI 02863 Phone: 401-726-8080 Fax: 401-726-8087 | |
Arlene J Atkins, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 621 Dexter St, Central Falls, RI 02863 Phone: 401-721-9200 Fax: 401-729-0010 | |
Briana Christina Rampino, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 Central St, Central Falls, RI 02863 Phone: 401-365-6811 Fax: 401-365-6813 | |
Rosemarie Jalette, LCDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 51 Clay St, Central Falls, RI 02863 Phone: 401-726-8080 Fax: 401-726-8087 | |
Joseph Favali, MASTERS Counselor Medicare: Not Enrolled in Medicare Practice Location: 51 Clay St, Central Falls, RI 02863 Phone: 401-726-8080 Fax: 401-726-8007 |